PPBT
Purple Biotech
PPBT
PPBT
12 hedge funds and large institutions have $311K invested in Purple Biotech in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
82% less capital invested
Capital invested by funds: $1.77M → $311K (-$1.46M)
Holders
12
Holding in Top 10
–
Calls
$261K
Puts
$73K
Top Buyers
| 1 | +$41.3K | |
| 2 | +$35.9K | |
| 3 | +$26.9K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$7.79K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$7.19K |
Top Sellers
| 1 | -$1.07M | |
| 2 | -$198K | |
| 3 | -$105K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$38.9K |